Price comparison between innovator and generic medicines sold by community pharmacies in the state of Penang, Malaysia

Journal of Generic Medicines

Volumn 6, Issue 1, 2008, Pages 35-42

  Shafie, Asrul Akmal ^a   Hassali, Mohamed Azmi ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; GENERIC DRUG; INNOVATOR DRUG; UNCLASSIFIED DRUG;

ARTICLE; COMMUNITY CARE; CONSUMER; COST BENEFIT ANALYSIS; COST CONTROL; DATA COLLECTION METHOD; DRUG COST; DRUG DOSAGE FORM; DRUG DOSE; DRUG MANUFACTURE; DRUG MARKETING; DRUG USE; MALAYSIA; PHARMACY;

EID: 67549085481     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2008.25     Document Type: Article

References (9)

1. World Health Organization, Health Action International (2003). Medicine Prices - A New Approach to Measurement, World Health Organization, Geneva. Available at: http://whqlibdoc.who.int/hq/2003/ WHO_EDM_PAR_2003.2.pdf, accessed 15th February, 2008.
2. Quick, J. D., Rankin, J. R., Laing, R. O., O'Connor, R.W., Hogerzeil, H.V., Dukes, M.N.G. & Garnett, A. (eds.)(1997). Managing Drug Supply 2nd edn,Kumarian Press, West Hartford (Connecticut), pp. 7-9.
3. Kanavos, P. (2007). Do generics offer significant savings to the UK National Health Service? Curr. Med. Res. Opin. 23, 105-116.
4. Kalisch, L. M., Roughead, E. E. & Gilbert, A. L. (2007). Pharmaceutical brand substitution in Australia - Are there multiple switches per prescription? Aust. NZ J. Public Health 31, 348-352.
5. Steinbrook, R. (2007). Closing the affordability gap for drugs in low-income countries. N. Engl. J. Med. 357(20), 1996-1999.
6. Directive 2004/27/EC of the European Parliament and of the Council of 31st March, 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L 136/34-57.
7. Babar, Z. U., Ibrahim, M. I., Singh, H., Bukahri, N. I. & Creese, A. (2007). Evaluating drug prices, availability, affordability, and price components: Implications for access to drugs in Malaysia. PLoS Med. 4(3), e82.
8. Babar, Z. U. & Ibrahim, M. I. (2003). Affordability of medicines in Malaysia - Consumer perceptions. Essent. Drugs Monit. 33, 18-19.
9. Pharmaceutical Services Division and the Clinical Research Centre Ministry of Health Malaysia (2007). Malaysian Statistics On Medicines 2005, Ministry of Health, Kuala Lumpur. Available at: http://www.crc.gov.my/nmus/publications.htm, accessed December 2007.